NCT01195142

Brief Summary

Adipose tissue is a central organ in mediating metabolic health. There is some evidence that women with polycystic ovary syndrome (PCOS) have a degree of adipose tissue dysfunction which may negatively affect their metabolic health. The aim of this study was to assess transcriptomic profiles of subcutaneous adipose tissue of women with PCOS in comparison with a control population matched on the basis of age and body mass index (BMI). A secondary aim was to then relate these gene expression profiles to the biochemical environment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2007

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2007

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2008

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

September 2, 2010

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 6, 2010

Completed
Last Updated

September 6, 2010

Status Verified

July 1, 2008

Enrollment Period

7 months

First QC Date

September 2, 2010

Last Update Submit

September 3, 2010

Conditions

Keywords

PCOS

Outcome Measures

Primary Outcomes (1)

  • Transcriptomic profiling of subcutaneous adipose tissue of women with PCOS and age and BMI matched controls

    Gene expression profiles from women with PCOS and controls matched for age and BMI were determined by microarray analysis of whole subcutaneous adipose tissue samples. Single gene changes as well as pathway analyses will be used to determine differently expressed genes and pathways between the PCOS cohort and controls.

    Recruitment ran from Dec 2007-July 2008. Subjects attended the study location fasting on one occasion

Secondary Outcomes (1)

  • Measurement of biomarkers of metabolic health (lipid, inflammatory markers) in plasma of PCOS cases and controls

    Recruitment ran from Dec 2007-July 2008. Subjects attended the study location fasting on one occasion

Study Arms (2)

PCOS-CSAT

Women with PCOS

Control-CSAT

Control population consisting of women without PCOS, matched for age and BMI with the PCOS cohort

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Women with PCOS and a control population of women matched for age and body mass index (BMI)

You may qualify if:

  • Had a positive diagnosis of PCOS as defined according to the NIH criteria as chronic oligomenorrhoea (\< 9 menstrual cycles per year) and clinical and/or biochemical evidence of hyperandrogenism, in the absence of other disorders causing the same phenotype. Clinical criteria included hirsutism with a Ferriman-Galwey score greater than 9, acne or male pattern alopecia; biochemical criteria included total-testosterone, androstenedione or dehydroepiandrosterone sulphate (DHEAS) greater than the laboratory reference range.
  • Were between the ages of 18 and 40

You may not qualify if:

  • Were under 18 years or greater than 40 years old,
  • Were non-Caucasian
  • Were pregnant, lactating or trying to conceive
  • Had a body mass index (BMI) \<18kg/m2 or \>50kg/m2
  • Had a recent illness or any chronic illness likely to influence results
  • Were taking hormonal contraception

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Diabetes Day Centre, The Adelaide and Meath Hosptial

Dublin, Dublin, 24, Ireland

Location

Nutrigenomics Group, University College Dublin

Dublin, Leinster, Dublin 4, Ireland

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Plasma

MeSH Terms

Conditions

Polycystic Ovary Syndrome

Condition Hierarchy (Ancestors)

Ovarian CystsCystsNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesGonadal DisordersEndocrine System Diseases

Study Officials

  • James Gibney, Dr

    The Adelaide and Meath Hospital

    PRINCIPAL INVESTIGATOR
  • Helen M Roche, Dr

    University College Dublin

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 2, 2010

First Posted

September 6, 2010

Study Start

December 1, 2007

Primary Completion

July 1, 2008

Study Completion

July 1, 2008

Last Updated

September 6, 2010

Record last verified: 2008-07

Locations